Dual Antiplatelet Therapy Role in Acute Ischemic Stroke (original) (raw)
Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
Imran khokhar
Cureus, 2018
View PDFchevron_right
Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic Attack
Philip Bath
Stroke, 2012
View PDFchevron_right
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility
Philip M Bath
PloS one, 2008
View PDFchevron_right
Trends in Usage of Alternative Antiplatelet Therapy After Stroke and Transient Ischemic Attack
Nancy Hills
Stroke, 2008
View PDFchevron_right
Antiplatelet therapy in secondary stroke prevention
Robert Talbert
Expert Opinion on Pharmacotherapy, 2001
View PDFchevron_right
Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study
Jannik Pallisgaard
BMC Neurology, 2015
View PDFchevron_right
Safety and Efficacy of Intensive vs. Guideline Antiplatelet Therapy in High-Risk Patients with Recent Ischemic Stroke or Transient Ischemic Attack: Rationale and Design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) Trial (ISRCTN47823388)
Philip M Bath
International Journal of Stroke, 2015
View PDFchevron_right
Combination aspirin and clopidogrel for secondary prevention of ischemic stroke
Oscar Alvarez Benavente
2013
View PDFchevron_right
Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
Philip Bath
Circulation, 2013
View PDFchevron_right
Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment Comparison Meta-analysis
Jennifer Donovan, Matthew Silva
Clinical Therapeutics, 2013
View PDFchevron_right
Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin
Hee-Joon Bae
Stroke; a journal of cerebral circulation, 2015
View PDFchevron_right
Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician
Philip M Bath
Clinical Medicine
View PDFchevron_right
Recent Clinical Trial Results with Antiplatelet Therapy: Implications in Stroke Prevention
Philip Teal
Cerebrovascular Diseases, 2004
View PDFchevron_right
Antiplatelets in Stroke Prevention
Antonio Pinto
Current Vascular Pharmacology, 2014
View PDFchevron_right
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke
Jacoba Greving
Stroke, 2021
View PDFchevron_right
EARLY antiplatelet treatment after ischaemic stroke
Harold Adams
The Lancet Neurology, 2010
View PDFchevron_right
Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke
Philip M Bath
View PDFchevron_right
Antiplatelet medication management in patients hospitalized with ischemic stroke
Joseph Biskupiak
American Journal of Health-System Pharmacy, 2007
View PDFchevron_right
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
Philip M Bath
Health technology assessment (Winchester, England), 2018
View PDFchevron_right
Update in dual antiplatelet therapy in patients with ischemic artery disease
Srdjan Aleksandric
2017
View PDFchevron_right
RETRACTED ARTICLE: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
Federick Cheng
BMC Neurology, 2020
View PDFchevron_right
Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack: An Updated Systematic Review and Meta-Analysis
Philip M Bath
Circulation, 2013
View PDFchevron_right
Characterization of Ischemic Events and Use of Prescription Antiplatelet and Anticoagulant Agents After Stroke or Transient Ischemic Attack
Hemal Shah
Journal of Stroke and Cerebrovascular Diseases, 2005
View PDFchevron_right
Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
Stephanie Ôunpuu, Philip M Bath
New England Journal of Medicine, 2008
View PDFchevron_right
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
William Barsan
The New England journal of medicine, 2018
View PDFchevron_right
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Jason Sico
Stroke, 2021
View PDFchevron_right
The Role of Antiplatelet agents in ischemic events
Sara Shreen
Journal of Drug Delivery and Therapeutics, 2021
View PDFchevron_right
Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial
Philip M Bath
International journal of stroke : official journal of the International Stroke Society, 2016
View PDFchevron_right
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy After Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment
Alessandro Sticchi
The American Journal of Cardiology
View PDFchevron_right
Dual versus single antiplatelet therapy for secondary prevention in ischaemic stroke or transient ischaemic attack: A retrospective cohort study using real-world data
sheamini sivasampu
2021
View PDFchevron_right
Antiplatelet Therapy After Noncardioembolic Stroke
Philip Bath
Stroke, 2019
View PDFchevron_right
Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
Farhan Khan
Frontiers in Neurology, 2021
View PDFchevron_right
Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke
Philip Bath
Stroke, 2010
View PDFchevron_right
Combined Antiplatelet Therapy: Still a Sweeping Combination in Cardiology
Antonis Manolis
Cardiovascular & Hematological Agents in Medicinal Chemistry, 2013
View PDFchevron_right